APOE and early-onset autosomal dominant Alzheimer disease: For example with the prioritization of APOE by models for Alzheimer’s disease (Mordelet and Vert, 2011; Wang et al., 2013; Deo et al., 2014), it could also be argued that this validates the model performance, as this gene is expected to be prioritized.